Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05549102
What this trial is testing

CBT and the Neural Circuits of Anxiety

Who this might be right for
Generalised Anxiety DisorderAnxiety DisordersCBT+6 more
UCLH/UCL Joint Research Office 174
Post-approval studies (Phase 4)Looking for participantsNCT07101445
What this trial is testing

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Who this might be right for
Multiple Myeloma
Emory University 94
Not applicableWithdrawnNCT03660072
What this trial is testing

Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb
Large-scale testing (Phase 3)Not Yet RecruitingNCT07181239
What this trial is testing

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma (MM)
Keymed Biosciences Co.Ltd 280
Testing effectiveness (Phase 2)Ended earlyNCT02225275
What this trial is testing

Lenalidomide and Obinutuzumab in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 9
Large-scale testing (Phase 3)Ended earlyNCT03670901
What this trial is testing

Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
JHL Biotech, Inc. 8
Testing effectiveness (Phase 2)Looking for participantsNCT05929612
What this trial is testing

Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT01919086
What this trial is testing

Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT00274651
What this trial is testing

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Who this might be right for
Cutaneous T-Cell LymphomaPeripheral T-Cell LymphomaNon-Hodgkin's Lymphoma
Valerio Therapeutics 53
Testing effectiveness (Phase 2)Study completedNCT02400437
What this trial is testing

Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT02363439
What this trial is testing

Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401

Who this might be right for
Waldenstrom's Macroglobulinemia
Idera Pharmaceuticals, Inc. 5
Early research (Phase 1)Looking for participantsNCT07660939
What this trial is testing

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

Who this might be right for
Plasma Cell DisordersMultiple Myeloma (MM)
Peking University First Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00083577
What this trial is testing

Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 250
Testing effectiveness (Phase 2)Study completedNCT00001575
What this trial is testing

Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia

Who this might be right for
Hodgkin's DiseaseLymphoma, Non-Hodgkin
National Cancer Institute (NCI) 87
Testing effectiveness (Phase 2)Ended earlyNCT01621477
What this trial is testing

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+4 more
St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT06524375
What this trial is testing

Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period

Who this might be right for
Chronic Lymphocytic Leukemia
Genentech, Inc. 118
Not applicableStudy completedNCT01804101
What this trial is testing

Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
Fred Hutchinson Cancer Center 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07680166
What this trial is testing

An Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

Who this might be right for
Pulmonary Sarcoidosis
Xentria, Inc. 182
Testing effectiveness (Phase 2)Study completedNCT05093322
What this trial is testing

Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Solid TumorLymphomaOsteosarcoma+3 more
Hutchmed 13
Early research (Phase 1)Active Not RecruitingNCT04847453
What this trial is testing

Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

Who this might be right for
Recurrent AL AmyloidosisRefractory AL Amyloidosis
National Cancer Institute (NCI) 24
Next Page